Tech Company Financing Transactions
Innervace Funding Round
Innervace closed a $40 million Series A investment round on 9/8/2022. Investors included Deerfield Management Company, BioAdvance Ventures and IP Group.
Transaction Overview
Company Name
Announced On
9/8/2022
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to accelerate efforts to develop its lead program, which aims to reconstruct the lost nigrostriatal pathway in patients with Parkinson's Disease, and enable licensing of a cell source with a specific (A9) dopaminergic phenotype from a research collaboration between UC San Diego and Deerfield Management.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
345 Park Ave. South
New York, NY 10010
USA
New York, NY 10010
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Innervace spun out of the University of Pennsylvania is a company focused on the development and commercialization of anatomically inspired living scaffolds for brain pathway reconstruction.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nader Halim
Browse more venture capital transactions:
Prev: 9/8/2022: Latana venture capital transaction
Next: 9/8/2022: Nexford University venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs